Pricing Log in Create free account

Bluejay Diagnostics, Inc. (BJDX) vs Trinity Biotech PLC (TRIB)

Bluejay Diagnostics, Inc. and Trinity Biotech PLC are both Medical Devices companies. Trinity Biotech PLC is the larger, with a market value of $5.1M against $3.5M — 1.5× the size. Trinity Biotech PLC has negative trailing earnings, so its P/E is not meaningful; Bluejay Diagnostics, Inc. trades at 0.9×. Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −70.1%) and the higher return on invested capital (0.00% vs −12.6%). Across the 13 metrics below, Bluejay Diagnostics, Inc. leads on 7 and Trinity Biotech PLC on 6.

Valuation

Metric BJDX TRIB Medical Devices median
P/E 0.93 n/m 23.22
P/S n/m 0.11 2.34
P/B 0.16 n/m 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA 0.46 n/m 11.54
EV/Sales n/m 2.98 2.24
Earnings yield 107.76% (647.03%) (10.09%)
Free cash flow yield (405.35%) (243.50%) (8.47%)

Profitability

Metric BJDX TRIB Medical Devices median
Gross margin 0.00% 39.99% 56.01%
Operating margin 0.00% (25.43%) (15.03%)
Net margin 0.00% (70.07%) (20.40%)
Free cash flow margin 0.00% (9.10%) (7.24%)
Return on equity (98.89%) 55.26% (15.32%)
Return on assets (81.07%) (32.70%) (19.72%)
Return on invested capital 0.00% (12.61%) (10.33%)

Growth

Metric BJDX TRIB Medical Devices median
Revenue growth (TTM) — (13.52%) 8.80%
EPS growth (last fiscal year) 96.66% (12.99%) 29.03%
Revenue growth, 5-year CAGR — (15.56%) 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BJDX TRIB Medical Devices median
Debt to equity 0.00 (1.81) 0.07
Current ratio 4.64 0.22 2.50
Net debt to EBITDA 0.76 (9.92) 0.49

Dividend

Metric BJDX TRIB Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric BJDX TRIB Medical Devices median
Market cap 3.48m 5.08m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack